Dynamic42 interviewed by OTZ
In the run-up to the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed by the Ostthüringer Zeitung newspaper about our development, with which we managed to make it into the top 20. Read the complete interview here.
Read more News now:
News
Press Release | Dynamic42 launches Tumor Microenvironment Kit to advance complex in vitro cancer research
Dynamic42 GmbH announces the market launch of its Tumor Microenvironment (TME) Kit. The new product enables the creation of perfused 3D tumor models that reproduce the complexity of the human tumor microenvironment.
Read MoreNews
Press Release | Ohio Lumex Named Exclusive U.S. Distributor for Dynamic42’s Advanced Organ-on-Chip Technology
Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.
Read MoreNews, News-Cancer
Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer
Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.
Read More